UK markets closed
  • FTSE 100

    7,556.23
    -2.26 (-0.03%)
     
  • FTSE 250

    19,363.28
    -46.14 (-0.24%)
     
  • AIM

    853.32
    +2.76 (+0.32%)
     
  • GBP/EUR

    1.1660
    +0.0017 (+0.15%)
     
  • GBP/USD

    1.2296
    +0.0040 (+0.33%)
     
  • BTC-GBP

    13,849.69
    +20.20 (+0.15%)
     
  • CMC Crypto 200

    404.33
    +2.91 (+0.72%)
     
  • S&P 500

    4,071.70
    -4.87 (-0.12%)
     
  • DOW

    34,429.88
    +34.87 (+0.10%)
     
  • CRUDE OIL

    80.34
    -0.88 (-1.08%)
     
  • GOLD FUTURES

    1,797.30
    -3.80 (-0.21%)
     
  • NIKKEI 225

    27,777.90
    -448.18 (-1.59%)
     
  • HANG SENG

    18,675.35
    -61.09 (-0.33%)
     
  • DAX

    14,529.39
    +39.09 (+0.27%)
     
  • CAC 40

    6,742.25
    -11.72 (-0.17%)
     

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market to Reach $6.2 Billion by 2027

ReportLinker
ReportLinker

Abstract: What’s New for 2022? Global competitiveness and key competitor percentage market shares. Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Industry" - https://www.reportlinker.com/p06361342/?utm_source=GNW
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market to Reach $6.2 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers estimated at US$4 Billion in the year 2020, is projected to reach a revised size of US$6.2 Billion by 2027, growing at a CAGR of 6.6% over the analysis period 2020-2027. Hemostats, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$2.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Internal Tissue Sealants segment is readjusted to a revised 6.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 11.3% CAGR

The Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 11.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 6.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$828.4 Million by the year 2027.

Adhesion Barriers Segment to Record 5.7% CAGR

In the global Adhesion Barriers segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$759.6 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 7% CAGR through the analysis period.

Select Competitors (Total 44 Featured) -
Axio Biosolutions Private Limited
Beacon Senior Advisors
Chitogen, Inc.
Corlison Pte. Limited
Ethicon US LLC
GELITA MEDICAL
LifeBond Ltd.
Tissuemed Ltd.


Read the full report: https://www.reportlinker.com/p06361342/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Surgical Hemostats, Internal Tissue Sealants, and Adhesion
Barriers - Global Key Competitors Percentage Market Share in
2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Hemostats by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Hemostats by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Hemostats by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Internal Tissue Sealants by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Internal Tissue Sealants by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Internal Tissue Sealants
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Adhesion Barriers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Adhesion Barriers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Adhesion Barriers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Surgical Repair Applications by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Surgical Repair
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Surgical Repair
Applications by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Trauma Cases by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Trauma Cases by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Trauma Cases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Specialty Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Specialty Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Specialty Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 25: World Surgical Hemostats, Internal Tissue Sealants
and Adhesion Barriers Market Analysis of Annual Sales in US$
Million for Years 2012 through 2027

Table 26: World Recent Past, Current & Future Analysis for
Ambulatory Surgery Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 27: World Historic Review for Ambulatory Surgery Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 28: World 15-Year Perspective for Ambulatory Surgery
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

III. MARKET ANALYSIS

UNITED STATES
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United States for 2022 (E)
Table 29: USA Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 30: USA Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 31: USA 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2012, 2021 &
2027

Table 32: USA Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 33: USA Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Application - Surgical
Repair Applications and Trauma Cases Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 34: USA 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2012, 2021 & 2027

Table 35: USA Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 36: USA Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by End-Use - Hospitals,
Ambulatory Surgery Centers and Specialty Clinics Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 37: USA 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2012, 2021 &
2027

CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 39: Canada Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 40: Canada 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2012, 2021 &
2027

Table 41: Canada Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 42: Canada Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 43: Canada 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2012, 2021 & 2027

Table 44: Canada Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 45: Canada Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 46: Canada 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2012, 2021 &
2027

JAPAN
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Japan for 2022 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 48: Japan Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 49: Japan 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2012, 2021 &
2027

Table 50: Japan Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 51: Japan Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 52: Japan 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2012, 2021 & 2027

Table 53: Japan Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 54: Japan Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 55: Japan 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2012, 2021 &
2027

CHINA
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in China for 2022 (E)
Table 56: China Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 57: China Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 58: China 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2012, 2021 &
2027

Table 59: China Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 60: China Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 61: China 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2012, 2021 & 2027

Table 62: China Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 63: China Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 64: China 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2012, 2021 &
2027

EUROPE
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Europe for 2022 (E)
Table 65: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 66: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Geographic
Region - France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 67: Europe 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Geographic
Region - Percentage Breakdown of Value Sales for France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets
for Years 2012, 2021 & 2027

Table 68: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 69: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 70: Europe 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2012, 2021 &
2027

Table 71: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 72: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 73: Europe 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2012, 2021 & 2027

Table 74: Europe Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 75: Europe Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 76: Europe 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2012, 2021 &
2027

FRANCE
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in France for 2022 (E)
Table 77: France Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 78: France Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 79: France 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2012, 2021 &
2027

Table 80: France Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 81: France Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 82: France 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2012, 2021 & 2027

Table 83: France Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 84: France Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 85: France 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2012, 2021 &
2027

GERMANY
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Germany for 2022 (E)
Table 86: Germany Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 87: Germany Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 88: Germany 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2012, 2021 &
2027

Table 89: Germany Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 90: Germany Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 91: Germany 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2012, 2021 & 2027

Table 92: Germany Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 93: Germany Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 94: Germany 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2012, 2021 &
2027

ITALY
Table 95: Italy Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 96: Italy Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 97: Italy 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2012, 2021 &
2027

Table 98: Italy Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 99: Italy Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Surgical Repair Applications and Trauma Cases Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 100: Italy 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2012, 2021 & 2027

Table 101: Italy Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 102: Italy Historic Review for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Hospitals, Ambulatory Surgery Centers and Specialty Clinics
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 103: Italy 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Ambulatory
Surgery Centers and Specialty Clinics for the Years 2012, 2021 &
2027

UNITED KINGDOM
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United Kingdom for 2022 (E)
Table 104: UK Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Product Type - Hemostats, Internal Tissue Sealants
and Adhesion Barriers - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 105: UK Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Product Type -
Hemostats, Internal Tissue Sealants and Adhesion Barriers
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 106: UK 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Product Type -
Percentage Breakdown of Value Sales for Hemostats, Internal
Tissue Sealants and Adhesion Barriers for the Years 2012, 2021 &
2027

Table 107: UK Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by Application - Surgical Repair Applications and
Trauma Cases - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 108: UK Historic Review for Surgical Hemostats, Internal
Tissue Sealants and Adhesion Barriers by Application - Surgical
Repair Applications and Trauma Cases Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 109: UK 15-Year Perspective for Surgical Hemostats,
Internal Tissue Sealants and Adhesion Barriers by Application -
Percentage Breakdown of Value Sales for Surgical Repair
Applications and Trauma Cases for the Years 2012, 2021 & 2027

Table 110: UK Recent Past, Current & Future Analysis for
Surgical Hemostats, Internal Tissue Sealants and Adhesion
Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and
Specialty Clinics - Independent Analysis of Annual Sales in US$

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06361342/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001